Screener
Lifecore Biomedical, Inc. LFCR Balance Sheet Statement
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| $17.24M— | $20.8M+152% | $17.47M+223% | $18.86M+99.4% | —— | ||
| $25.48M— | $28.16M-12.8% | $29.09M-15.9% | $33.8M-13.8% | —— | ||
| $83.69M— | $77.64M-9.4% | $82.29M-2.3% | $83.93M+2.5% | —— | ||
| $123.71M— | $125.51M-2.7% | $127.3M-0.7% | $128.58M-14.6% | —— | ||
| $13.88M— | $13.88M0.0% | $13.88M0.0% | $13.88M0.0% | —— | ||
| $229.5M— | $225.5M-5.8% | $232.18M-2.3% | $235.2M-7.9% | —— | ||
| $7.53M— | $7.01M-14.7% | $6.21M-16.1% | $10.12M-32.4% | —— | ||
| $970K— | $962K-72.0% | $954K+2.6% | $947K+22.5% | —— | ||
| $21.64M— | $20.5M-32.1% | $23.57M-24.2% | $29.96M-15.1% | —— | ||
| —— | $148.74M— | $142.24M+13.8% | —— | —— | ||
| $213.41M— | $204.72M+6.7% | $198.12M+4.1% | $198.42M+1.4% | —— | ||
| $38K— | $75M+202,603% | $37K-100.0% | $37K-100.0% | —— | ||
| -$244.34M— | -$238.18M-16.0% | -$223.2M-9.4% | -$218.1M-13.9% | —— | ||
| -$34.09M-3,860% | -$28.44M-2,229% | -$14.2M-739% | -$10.54M-168% | -$861K+78.1% | ||
| $229.5M— | $225.5M-5.8% | $232.18M-2.3% | $235.2M-7.9% | —— |
FAQ
- What are Lifecore Biomedical, Inc.'s total assets?
- Lifecore Biomedical, Inc. (LFCR) holds $229.5M in total assets.
- How much debt does Lifecore Biomedical, Inc. have?
- Lifecore Biomedical, Inc. carries $8.1M in total debt against -$34.1M of shareholders' equity, a debt-to-equity ratio of 8.33.
- How much cash does Lifecore Biomedical, Inc. have?
- Lifecore Biomedical, Inc. holds $17.2M in cash and equivalents.
- Can Lifecore Biomedical, Inc. cover its short-term obligations?
- Its current ratio is 3.87 — current assets exceed current liabilities.
- Where does Lifecore Biomedical, Inc.'s balance sheet data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.